CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Medtronic has reported revenue gains across several of its medical device franchises, leading the company to ... aortic valve ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...

The American Heart Association held its annual Scientific Sessions Nov. 16-18 in Chicago, where healthcare organizations and industry leaders presented the latest research on cardiovascular health.

Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and ...

Medtronic stock slumped early Tuesday despite beating fiscal second-quarter expectations after a supplier issue impacted its cardiac ablation division. Please watch the video at Investors.com - How To ...